Wong YM, Webber MJ, Dickenson AH, Hunt SP (2006) Molecular changes in the dorsal horn that maintain inflammatory hyperalgesia are similar to those generated during long-term potentiation. Neuroscience 2006 Abstracts 642.17. Society for Neuroscience, Atlanta, GA.
Summary: The generation of LTP in deep dorsal horn neurons by noxious stimulation may be one mechanism whereby acute pain transforms into a chronic pain state. Spinal LTP requires the activation of a subset of superficial dorsal horn neurons that express the neurokinin-1 receptor (NK1-R) and are crucial for the initiation and maintenance of chronic pain states. These neurons participate in local spinal sensory processing and are the origin of a spino-bulbo-spinal loop that drives descending spinal facilitation. Spinal LTP is correlated with increased neuronal expression of the transcription factor zif268 in the superficial dorsal horn. Here, we examined if inflammatory pain states required LTP-like changes in gene expression that are dependent upon an intact lamina I pathway. We also asked if changing levels of zif268 regulated the glucocorticoid receptor (GR) gene, a downstream target of zif268. NK1 expressing neurons in lamina I of the lumbar spinal cord were selectively ablated using SP-SAP applied intrathecally. 28d later, rats were injected with Complete Freunds’ Adjuvant (CFA) (50%, 100μl) 2h prior to perfusion with 4% paraformaldehyde. Using immunohistochemistry, we found that while levels of c-fos immunoreactivity were unchanged by lamina I ablation, the levels of zif268 had decreased by 36% (p<0.05) compared to controls. We therefore treated rats intrathecally with zif268 antisense or missense oligonucleotides (0.16μg/μl/h) via implanted osmotic mini pumps and assessed the behavioural effects of zif268 ‘knockdown’ on inflammatory hyperalgesia. Animals were perfused 4 days after CFA inflammation and protein levels of zif268 and GR were assessed by immunohistochemistry. Antisense, but not missense zif268 treatment, reduced the levels of zif268 by 37% and reduced behavioural allodynia by 40%, but only at days 2-4 post CFA. Levels of GR were also reduced by 30% following zif268 antisense treatment. We therefore applied antisense and missense GR probes intrathecally.This reduced the inflammatory hyperalgesia score by 38% but again only on days 2-4. These results suggest the zif268 gene is essential for the maintenance but not the induction of inflammatory pain states and that zif268 can regulate GR in the spinal cord.
Related Products: SP-SAP (Cat. #IT-07)